Cardiovascular health describes how effectively your heart and blood vessels deliver oxygen and nutrients throughout your body. It includes more than the absence of heart disease. Blood pressure, cholesterol, blood glucose, body composition, physical activity, diet, sleep, and nicotine exposure all contribute to cardiovascular health.
This matters because cardiovascular disease remains the leading cause of death worldwide. The World Health Organization estimates that cardiovascular diseases caused 19.8 million deaths in 2022, representing approximately 32% of deaths globally.1 Many underlying blood-vessel changes can develop without obvious symptoms before a heart attack, stroke, or another serious event occurs.
Cardiovascular health is also closely associated with longevity. In a U.S. observational analysis published in 2023, adults with high cardiovascular-health scores at age 50 had an estimated 8.9 additional years of life expectancy compared with adults who had low scores.3 This finding does not guarantee a particular lifespan for any individual, but it illustrates why heart and blood-vessel health is central to both lifespan and healthspan—the years lived with good function and fewer chronic conditions.
Laboratory testing can provide objective information about cholesterol, atherogenic particles, inherited lipid risk, blood sugar, inflammation, and kidney function. Ulta Lab Tests offers direct online access to many relevant tests where available, helping patients gather information for more informed conversations with qualified healthcare providers.
Medical disclaimer: Laboratory testing provides health information but does not, by itself, diagnose cardiovascular disease, predict exactly who will have a heart attack or stroke, or replace professional medical evaluation.
Direct answer: Cardiovascular health is the overall condition of the heart, arteries, veins, and metabolic factors that influence blood flow, vascular function, and atherosclerosis.
The American Heart Association organizes cardiovascular health around Life’s Essential 8: healthy eating, physical activity, avoiding nicotine exposure, healthy sleep, healthy body weight, healthy blood lipids, healthy blood glucose, and healthy blood pressure.2 This framework recognizes that cardiovascular health is shaped by both daily behaviors and measurable biological factors.
Atherosclerosis is the gradual accumulation of cholesterol-rich plaque within artery walls. It may progress silently for years. High LDL cholesterol, high blood pressure, elevated blood glucose, and elevated lipoprotein(a), or Lp(a), also usually do not produce reliable early symptoms.
Feeling well therefore does not necessarily mean every cardiovascular risk factor is favorable. Blood tests can reveal objective patterns that symptoms alone cannot show, although laboratory tests do not directly visualize arterial plaque or measure how strongly the heart pumps.
Direct answer: The cardiovascular system supports every organ, so long-term damage to the heart and blood vessels can affect the brain, kidneys, muscles, and the ability to remain active and independent with age.
Your heart and blood vessels continuously transport oxygen, nutrients, hormones, and immune cells. They also help remove carbon dioxide and other metabolic waste. When arteries become narrowed, stiff, or damaged, the consequences can extend far beyond the heart.
Poor cardiovascular health is associated with conditions that can limit lifespan and healthspan, including coronary artery disease, heart attack, stroke, heart failure, peripheral artery disease, chronic kidney disease, and type 2 diabetes with vascular complications.
The relationship is cumulative. Years of exposure to elevated atherogenic particles, high blood pressure, high glucose, tobacco smoke, poor sleep, or inactivity may matter more than a single isolated measurement. Earlier awareness and long-term trends can help patients and healthcare providers identify which risk factors deserve attention.
Research using Life’s Essential 8 has associated higher cardiovascular-health scores with longer life and more years free of major chronic illness.3 These population-level associations do not prove that a particular score guarantees a specific outcome, but they support cardiovascular health as a practical framework for healthy aging.
Direct answer: Inflammation participates in the development and instability of atherosclerotic plaque, but inflammation tests must be interpreted carefully because they do not identify the source of inflammation.
C-reactive protein is produced by the liver in response to inflammatory signals. A high-sensitivity C-reactive protein test, or hs-CRP, detects lower concentrations than a standard CRP test and may add cardiovascular-risk information in selected patients.
Persistently elevated hs-CRP has been associated with greater cardiovascular risk, including among some people whose standard cholesterol results do not appear markedly abnormal.7 The Cardio IQ™ hs-CRP Test measures this inflammatory marker.
However, hs-CRP is nonspecific. It may rise because of an infection, recent injury or surgery, autoimmune or inflammatory disease, obesity, smoking, poor sleep, or another acute or chronic condition. A high result does not prove that inflammation is coming from the arteries. A healthcare provider may recommend repeating an elevated value when the patient is well and considering it alongside lipids, blood pressure, glucose, medical history, and other findings.8
A standard lipid panel remains the foundation of lipid assessment, but it does not answer every question. Advanced biomarkers may identify risk that is less apparent from LDL cholesterol alone.
Apolipoprotein B, or ApoB, is present on the particles that can deposit cholesterol in artery walls. Each major atherogenic particle carries one ApoB molecule, so ApoB provides an estimate of the total number of potentially plaque-forming particles.
Two people may have similar LDL-cholesterol concentrations but different numbers of particles carrying that cholesterol. The Cardio IQ™ Apolipoprotein B Test may be particularly informative when triglycerides are elevated or when diabetes, obesity, metabolic syndrome, cardiovascular-kidney-metabolic syndrome, or known cardiovascular disease is present.5
Lipoprotein(a), abbreviated Lp(a), is an LDL-like particle whose concentration is largely determined by genetics. Elevated Lp(a) may increase the risk of atherosclerotic cardiovascular disease and calcific aortic-valve disease even when other cholesterol measurements appear acceptable.
The 2026 ACC/AHA dyslipidemia guideline recommends measuring Lp(a) at least once in adulthood. The guideline describes a level of 125 nmol/L or greater, or 50 mg/dL or greater in the applicable reporting system, as elevated. These units are not directly interchangeable through one universal conversion, so the result should be interpreted in the unit reported by the laboratory.4
Ulta Lab Tests offers both the Cardio IQ™ Lipoprotein (a) Test and the Lipoprotein (a) Test. Review the product details and discuss the most appropriate option with a qualified healthcare provider.
Some panels report LDL particle number, LDL size, small and medium LDL particles, and other lipoprotein characteristics. The Lipoprotein Fractionation, NMR with Lipid Panel is one option that provides particle-related information.
More data are not always more useful. For many patients, a standard lipid panel plus ApoB and Lp(a), interpreted with overall cardiovascular risk, may answer the most important questions. Advanced particle testing is most useful when the information could influence a clinical conversation.
| Symptom or risk factor | What it may suggest | Tests that may provide additional information |
|---|---|---|
| Family history of early heart attack, stroke, or very high cholesterol | Possible inherited lipid risk | Lipid Panel Test, Cardio IQ™ Apolipoprotein B Test, and Cardio IQ™ Lipoprotein (a) Test |
| High triglycerides, diabetes, obesity, or metabolic syndrome | Increased cardiometabolic and particle-related risk | Lipid Panel Test, Cardio IQ™ Apolipoprotein B Test, A1c Test, and Glucose Test |
| High blood pressure, tobacco exposure, inactivity, or poor sleep | Cumulative vascular stress | Lipid Panel and Comprehensive Metabolic Panel-CMP, A1c Test, and correctly measured blood pressure |
| Diabetes, hypertension, or chronic kidney disease risk | Cardio-kidney risk or possible vascular damage | Kidney Profile and Albumin Random Urine Test with Creatinine |
| Chronic inflammatory condition or unexplained persistent inflammation | Systemic inflammatory burden | Cardio IQ™ hs-CRP Test when clinically stable, plus condition-specific evaluation |
| Chest pressure, severe shortness of breath, cold sweat, fainting, sudden weakness, speech difficulty, or facial drooping | Possible heart attack, stroke, or another emergency | Do not wait for direct-access testing; seek emergency medical care |
Safety note: Sudden chest pain, severe shortness of breath, fainting, or stroke-like symptoms require urgent medical evaluation rather than routine wellness testing.
Testing may be worth discussing when:
Testing should be individualized. Not every person needs every advanced biomarker, and repeating a stable inherited marker such as Lp(a) is generally less useful than monitoring modifiable risk factors unless a provider recommends otherwise.
Those questions may require a medical history, physical examination, blood-pressure measurement, electrocardiogram, imaging, stress testing, coronary artery calcium assessment, or another clinician-directed evaluation. No single laboratory result should usually be interpreted in isolation.
| Lab test or biomarker | What it measures | Why it may be relevant | What results may generally suggest | Important limitations |
|---|---|---|---|---|
| Lipid Panel Test | Total cholesterol, LDL-C, HDL-C, and triglycerides | Provides a foundational assessment of lipid-related cardiovascular risk | Higher LDL-C or triglycerides and lower HDL-C may form a less favorable pattern | Does not directly count atherogenic particles or show whether plaque is present |
| Cardio IQ™ Apolipoprotein B Test | ApoB-containing atherogenic particle burden | May clarify risk when LDL-C and particle number are discordant | Higher ApoB generally indicates more circulating atherogenic particles | Does not show whether plaque is already present |
| Cardio IQ™ Lipoprotein (a) Test | Concentration of genetically influenced Lp(a) particles | Identifies an inherited risk factor that is not included in a standard lipid panel | Higher values may increase atherosclerotic cardiovascular and aortic-valve risk | Units and thresholds require careful interpretation; lifestyle has limited effect on the inherited level |
| Cardio IQ™ hs-CRP Test | Low concentrations of C-reactive protein | Adds information about systemic inflammation and cardiovascular risk in selected patients | Persistently higher values may indicate greater inflammatory burden | Infection, injury, surgery, and inflammatory disease can elevate the result |
| A1c Test | Average blood glucose over approximately two to three months | Helps assess chronic glucose exposure that may affect blood vessels | Higher values indicate higher average glucose | Some blood disorders, kidney disease, pregnancy, blood loss, and other factors may affect interpretation |
| Hemoglobin A1c and Glucose Panel | Longer-term glucose exposure and a current glucose measurement | Provides complementary information about glycemic status | Elevated results may support follow-up for impaired glucose regulation | Fasting requirements and interpretation depend on the included tests and individual context |
| Lipid Panel and Comprehensive Metabolic Panel-CMP | Lipids plus glucose, electrolytes, proteins, kidney markers, and liver markers | Provides broad cardiovascular and metabolic context | Abnormal lipids, glucose, creatinine, liver markers, or electrolytes may require follow-up | Hydration, fasting, medications, and recent illness can influence several components |
| Kidney Profile | Kidney filtration and urine albumin-related markers included in the panel | Cardiovascular and kidney risks frequently overlap, especially with diabetes or hypertension | Lower estimated filtration or higher urine albumin may indicate increased cardio-kidney risk | Abnormal findings may need confirmation, and kidney testing is not equally necessary for every low-risk adult |
| Albumin Random Urine Test with Creatinine | Urine albumin and creatinine used to assess albumin loss | May reveal early kidney damage even when serum creatinine appears acceptable | Persistently elevated albumin-to-creatinine results may suggest kidney damage or increased vascular risk | Exercise, infection, menstruation, and temporary illness may affect urine findings; persistence should be confirmed |
| Cardio IQ™ Advanced Lipid Panel with Inflammation | Standard lipids, selected particle measures, ApoB, and inflammation-related markers included in the panel | May consolidate testing when an advanced assessment is appropriate | Interpretation depends on the overall pattern rather than one isolated marker | More testing does not automatically improve clinical decisions |
A foundational assessment may include the Lipid Panel Test, the A1c Test and/or Glucose Test, correctly measured blood pressure, weight or body-composition assessment, and kidney markers when appropriate.
For a broader metabolic baseline, the Lipid Panel and Comprehensive Metabolic Panel-CMP combines lipid and metabolic information. Review its preparation instructions before collection.
Depending on medical history and foundational results, a patient and healthcare provider may discuss the Cardio IQ™ Apolipoprotein B Test, the Cardio IQ™ Lipoprotein (a) Test, and the Cardio IQ™ hs-CRP Test.
Lp(a) now has a broad once-in-adulthood testing recommendation. ApoB may be especially helpful when triglycerides are high or when diabetes, metabolic syndrome, or known cardiovascular disease creates possible discordance between LDL-C and particle burden. Hs-CRP may help when risk remains uncertain, but it is best interpreted when an acute illness is not distorting the result.
The Cardio IQ™ Advanced Lipid Panel with Inflammation or the Lipoprotein Fractionation, NMR with Lipid Panel may be considered when standard lipid measurements do not match the broader risk profile, there is a strong family history, several cardiometabolic risks occur together, or a qualified healthcare provider believes additional measurements may affect risk assessment.
Repeat testing may be appropriate after a previously abnormal result, a significant lifestyle change, a clinician-directed treatment change, recovery from an illness that may have distorted hs-CRP or metabolic results, or at an interval recommended for a known cardiovascular, metabolic, or kidney condition.
Whenever possible, compare results obtained under similar preparation conditions and through the same laboratory methodology.
A laboratory reference range describes values observed in a comparison population using that laboratory’s method. It does not always represent the ideal clinical target for every person.
For example, LDL-C or ApoB goals may differ for someone with no known risk factors compared with someone who has diabetes, chronic kidney disease, established atherosclerotic cardiovascular disease, or a history of stroke. Current dyslipidemia guidance uses individualized, risk-based goals rather than one universal target.4
Interpretation may be affected by age, sex, pregnancy, fasting status, hydration, recent illness, inflammation, strenuous exercise, medications, supplements, alcohol use, sample timing, and laboratory methodology.
An abnormal result does not automatically mean disease is present. A normal result does not completely rule out cardiovascular risk. Laboratory values should be interpreted with symptoms, medical history, other tests, and the specific reference interval shown on the report.11
A healthcare provider may consider whether LDL-C and ApoB agree, whether triglycerides and glucose are rising together, whether hs-CRP remains elevated when the patient is well, whether kidney function is stable, whether family history suggests inherited risk, and whether values have changed meaningfully over time.
This integrated approach is more useful than labeling one isolated result as simply “good” or “bad.”
Ulta Lab Tests supports patients who want convenient access to health information by offering:
Direct access can help patients establish a baseline, investigate a specific biomarker, or monitor selected results over time. It does not replace medical evaluation and should not delay urgent care for concerning symptoms.
Explore Heart and Cardiovascular Tests at Ulta Lab Tests.
Testing frequency depends on age, previous results, family history, existing conditions, and treatment. Check the specific instructions on every Ulta Lab Tests product page before ordering.
Cardiovascular health influences how effectively oxygen and nutrients reach the brain, kidneys, muscles, and other organs. Higher cardiovascular-health scores have been associated with longer life expectancy and more years free of major chronic disease. These studies show population-level associations rather than guarantees, but they support heart and blood-vessel health as a central component of healthy aging.
A foundational assessment often includes the Lipid Panel Test, the A1c Test, and/or the Glucose Test. Depending on personal risk, additional options may include the Cardio IQ™ Apolipoprotein B Test, Cardio IQ™ Lipoprotein (a) Test, Cardio IQ™ hs-CRP Test, and kidney testing.
Blood tests can identify risk factors and biomarkers associated with cardiovascular disease, but most cannot show whether an artery is narrowed or blocked. Diagnosing heart disease may require a medical examination, electrocardiogram, imaging, stress testing, or another evaluation. Direct-access testing should not be used to assess sudden chest pain, severe shortness of breath, fainting, or stroke-like symptoms.
Hs-CRP measures a low-level systemic inflammatory signal. Persistently elevated values may add cardiovascular-risk information, particularly when overall risk is uncertain. However, hs-CRP can also rise because of infection, injury, obesity, smoking, autoimmune disease, surgery, or another source of inflammation. Results from the Cardio IQ™ hs-CRP Test should be interpreted with other findings.
ApoB and LDL-C answer related but different questions. LDL-C estimates the amount of cholesterol carried in LDL particles, while ApoB estimates the number of atherogenic particles. The Cardio IQ™ Apolipoprotein B Test may provide additional insight when triglycerides are high or when diabetes, obesity, or metabolic syndrome creates a mismatch between cholesterol concentration and particle number.
Lp(a) is a largely inherited LDL-like particle associated with atherosclerotic cardiovascular disease and calcific aortic-valve disease when elevated. It is not included in a standard lipid panel. The 2026 ACC/AHA dyslipidemia guideline recommends at least one adult measurement. The Cardio IQ™ Lipoprotein (a) Test is one direct-access option.
Yes. A standard cholesterol panel may not capture high blood pressure, diabetes, kidney disease, smoking exposure, systemic inflammation, inherited Lp(a), or a high number of ApoB-containing particles. In addition, a value marked “normal” by the laboratory may not represent the most appropriate goal for every person. Results should be interpreted together rather than using one cholesterol value as a complete assessment.
Advanced biomarkers may be worth discussing when there is a strong family history, premature cardiovascular disease, diabetes, high triglycerides, metabolic syndrome, kidney disease, unexplained risk despite acceptable LDL-C, or uncertainty after a standard assessment. Lp(a) has a broad once-in-adulthood recommendation, while ApoB, hs-CRP, and particle analysis are generally selected according to clinical context.
Ulta Lab Tests allows patients to order many cardiovascular tests directly online where available. Pricing is shown before ordering, insurance is not required, and results are delivered securely online. Direct access does not replace medical care. A qualified healthcare provider should review results in the context of medical history, symptoms, medications, blood pressure, and overall risk.
The appropriate interval depends on the biomarker, initial result, age, medical history, medications, and overall risk. Modifiable factors such as lipids, A1c, glucose, and kidney markers may be monitored periodically. Lp(a) is largely inherited and usually does not require frequent repetition. Elevated hs-CRP may be repeated when acute illness or another temporary trigger has resolved.
Cardiovascular health and longevity are closely connected because the heart and blood vessels support every organ and influence the risk of many age-related conditions. Risk often develops silently, making objective information from lipid, glucose, inflammation, inherited-risk, and kidney biomarkers valuable when testing is selected appropriately.
The Lipid Panel Test and a glucose assessment such as the A1c Test provide a strong starting point. The Cardio IQ™ Apolipoprotein B Test, Cardio IQ™ Lipoprotein (a) Test, and Cardio IQ™ hs-CRP Test may reveal additional risk in the right context. Advanced testing should complement—not replace—blood-pressure measurement, medical history, healthy behaviors, and professional evaluation.
Explore cardiovascular lab tests at Ulta Lab Tests to establish a baseline or investigate selected biomarkers. Review all results with a qualified healthcare provider before making health or treatment decisions.
Cardiovascular health is the condition of the heart, blood vessels, and related metabolic factors such as blood pressure, blood lipids, glucose, body weight, sleep, activity, and nicotine exposure. Better cardiovascular health is associated with longer life expectancy and more years lived without major chronic disease.
Related lab tests: Lipid Panel Test, Cardio IQ™ Apolipoprotein B Test, Cardio IQ™ Lipoprotein (a) Test, Cardio IQ™ hs-CRP Test, A1c Test, Hemoglobin A1c and Glucose Panel, Kidney Profile, and Albumin Random Urine Test with Creatinine.
How Ulta Lab Tests helps: Ulta Lab Tests provides direct online access to many cardiovascular laboratory tests where available, with transparent pricing and secure online results.
Disclaimer: Laboratory testing is informational and should be interpreted with a qualified healthcare provider.
These are the article’s foundational tests for cholesterol, triglycerides, current glucose, longer-term glucose exposure, and broader metabolic context.
These tests support the article’s discussion of atherogenic particle burden, inherited Lp(a)-related risk, and advanced lipoprotein analysis.
These pages align with the article’s explanation of systemic inflammation, hs-CRP, standard lipids, advanced lipid markers, and integrated cardiovascular risk assessment.
These pages are the most directly relevant internal-link destinations for the article’s cardiovascular-risk, lipid, ApoB, Lp(a), and heart-health sections.
These supporting areas connect the article to inflammation, glucose regulation, kidney health, weight, physical activity, preventive health, and healthy-aging search intent.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
